1335 studies found for:    "Thrombosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Anticoagulation Length in Cancer Associated Thrombosis
Conditions: Cancer;   Thrombosis;   Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolus
Intervention: Drug: Low Molecular Weight Heparin (LMWH)
2 Unknown  Rosuvastatin for Preventing Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous;   Thrombosis;   Prevention
Interventions: Drug: Rosuvastatin 20mg/d for 14days;   Drug: enoxaparin only
3 Recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
4 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
5 Completed
Has Results
Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Device: DVT-3000;   Device: SCD Express
6 Completed
Has Results
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
Conditions: Thrombosis, Venous;   Acute Deep Vein Thrombosis
Interventions: Drug: Fondaparinux sodium;   Drug: unfractionated heparin (UFH)
7 Completed Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
8 Completed A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate;   Drug: enoxaparin/unfractionated heparin;   Drug: warfarin
9 Active, not recruiting Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Conditions: Deep Vein Thrombosis;   Venous Thrombosis
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care
10 Completed Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Interventions: Drug: Xarelto (Rivaroxaban, BAY59-7939);   Drug: Enoxaparin/Vitamin K-Antagonist
11 Terminated Anticoagulation Post Laparoscopic Splenectomy
Conditions: Portal Vein Thrombosis;   Splenic Vein Thrombosis
Intervention: Drug: Enoxaparin
12 Completed Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism;   Thromboembolism;   Venous Thrombosis
Interventions: Drug: edoxaban tosylate(DU-176b);   Drug: low molecular weight heparin/unfractionated heparin;   Drug: warfarin
13 Recruiting Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
Conditions: Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions: Drug: BAY 59-7939;   Drug: ASA
14 Unknown  Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
15 Completed 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism;   Deep Vein Thrombosis With Pulmonary Embolism
Interventions: Drug: Duration of anticoagulation;   Drug: Warfarin duration
16 Completed Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
Conditions: Thrombosis;   Thromboembolism;   Venous Thrombosis
Intervention: Drug: Tinzaparin sodium
17 Withdrawn Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Rosuvastatin (AZD4522);   Drug: Placebo
18 Completed Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: warfarin accordingly INR value
19 Completed Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Condition: Deep Vein Thrombosis
Intervention: Drug: Warfarin
20 Recruiting Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
Condition: Sinus Thrombosis, Intracranial
Interventions: Drug: Endovascular thrombolysis;   Drug: Heparin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years